Overview
Krasimira Rozenova is a Hematologist in New Haven, Connecticut. Dr. Rozenova is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Marginal Zone Lymphoma (MZL), Monoclonal Gammopathy of Undetermined Significance (MGUS), Fanconi Anemia, and Congenital Aplastic Anemia.
Her clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
20 York St, New Haven, CT 06510
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Yale University
Natalia Neparidze is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Neparidze is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Splenectomy.
Trustees Of Columbia University In The City Of New York
Suzanne Lentzsch is an Oncologist and a Hematologist in New York, New York. Dr. Lentzsch is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy.
Yale University
Terri Parker is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Parker is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Schnitzler Syndrome, Smoldering Multiple Myeloma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Rozenova isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Congenital Aplastic AnemiaDr. Rozenova isExperienced. Learn about Congenital Aplastic Anemia.
- Fanconi AnemiaDr. Rozenova isExperienced. Learn about Fanconi Anemia.
- LeukemiaDr. Rozenova isExperienced. Learn about Leukemia.
- Marginal Zone Lymphoma (MZL)Dr. Rozenova isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)